Sematilide
Alternative Names: CK 1752; CK 1752A; ZK 110516Latest Information Update: 22 Mar 2010
At a glance
- Originator Bayer HealthCare Pharmaceuticals
- Class Aminobenzoic acids; Benzamides; Class III antiarrhythmics; Small molecules
- Mechanism of Action Potassium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Arrhythmias
Most Recent Events
- 04 Apr 2007 Berlex Inc has been acquired by Bayer HealthCare (MR 9074204)
- 26 Aug 2004 Aventis has merged with Sanofi-Synthelabo to form Sanofi-Aventis
- 29 Dec 1999 Hoechst Marion Roussel has merged with Rhône-Poulenc Rorer to form Aventis Pharma